DK1343472T3 - Thixotropisk næsespray - Google Patents
Thixotropisk næsesprayInfo
- Publication number
- DK1343472T3 DK1343472T3 DK01985877T DK01985877T DK1343472T3 DK 1343472 T3 DK1343472 T3 DK 1343472T3 DK 01985877 T DK01985877 T DK 01985877T DK 01985877 T DK01985877 T DK 01985877T DK 1343472 T3 DK1343472 T3 DK 1343472T3
- Authority
- DK
- Denmark
- Prior art keywords
- therapeutic treatment
- thixotropic
- preparation
- nasal spray
- nasal
- Prior art date
Links
- 230000009974 thixotropic effect Effects 0.000 title abstract 3
- 239000007922 nasal spray Substances 0.000 title abstract 2
- 229940097496 nasal spray Drugs 0.000 title abstract 2
- 230000001225 therapeutic effect Effects 0.000 abstract 5
- 208000026344 Nasal disease Diseases 0.000 abstract 4
- 208000030880 Nose disease Diseases 0.000 abstract 4
- 238000002360 preparation method Methods 0.000 abstract 4
- 241001465754 Metazoa Species 0.000 abstract 2
- 206010039085 Rhinitis allergic Diseases 0.000 abstract 1
- 239000013543 active substance Substances 0.000 abstract 1
- 201000010105 allergic rhinitis Diseases 0.000 abstract 1
- 238000004519 manufacturing process Methods 0.000 abstract 1
- 238000000034 method Methods 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0043—Nose
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/007—Pulmonary tract; Aromatherapy
- A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
Landscapes
- Health & Medical Sciences (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Otolaryngology (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Pulmonology (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Apparatus For Radiation Diagnosis (AREA)
- Macromolecular Compounds Obtained By Forming Nitrogen-Containing Linkages In General (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE10064950A DE10064950A1 (de) | 2000-12-23 | 2000-12-23 | Thixotropes Nasenspray |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DK1343472T3 true DK1343472T3 (da) | 2006-09-25 |
Family
ID=7668932
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK01985877T DK1343472T3 (da) | 2000-12-23 | 2001-12-13 | Thixotropisk næsespray |
Country Status (7)
| Country | Link |
|---|---|
| EP (1) | EP1343472B1 (da) |
| AT (1) | ATE326947T1 (da) |
| DE (2) | DE10064950A1 (da) |
| DK (1) | DK1343472T3 (da) |
| ES (1) | ES2266288T3 (da) |
| PT (1) | PT1343472E (da) |
| WO (1) | WO2002051379A2 (da) |
Families Citing this family (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP1374856A1 (en) * | 2002-06-18 | 2004-01-02 | Impetus AG | Oily thixotropic nasal spray |
| DK1539285T4 (da) † | 2002-09-03 | 2012-01-02 | Pharmacure Health Care Ab | Næsesprayer |
| WO2006004577A2 (en) * | 2004-03-12 | 2006-01-12 | Melbj Holdings, Llc | Lubricant for the ocular surface |
| US8455016B2 (en) | 2004-03-12 | 2013-06-04 | Melbj Holdings, Llc | Treatment for meibomian gland dysfunction or obstruction |
| DE102008006393A1 (de) * | 2008-01-28 | 2009-07-30 | Beiersdorf Ag | Verwendung von Lipidkomponenten gegen Pollenallergien |
| NL2001342C2 (nl) * | 2008-02-20 | 2009-08-24 | Cornelis Boegem | Balsem voor het afdekken van slijmvliezen tegen in de lucht aanwezige allergene stoffen, het gebruik van de balsem en een applicator voor de balsem. |
| DE102011010668A1 (de) | 2011-02-08 | 2012-08-09 | Ursapharm Arzneimittel Gmbh | Wässrige pharmazeutische Zusammensetzung zur Prävention und/oder Therapie allergisch gereizter Nasenschleimhaut und dessen Verwendung |
| MX395212B (es) * | 2011-05-15 | 2025-03-21 | Acerus Biopharma Inc | Geles nasales de liberación controlada de testosterona, métodos y sistemas aplicadores multidosis pre cargados para administración pernasal. |
| WO2013049539A1 (en) * | 2011-09-30 | 2013-04-04 | Mcneil-Ppc, Inc. | A method of blocking or trapping allergens |
| WO2017023162A1 (en) * | 2015-08-04 | 2017-02-09 | Inqpharm Group Sdn Bhd | A nasal composition |
| KR102387241B1 (ko) | 2016-06-03 | 2022-04-15 | 엠 이티 피 파마 아게 | 다공성 부형제를 갖는 비강용 약제학적 조성물 |
| HUE063346T2 (hu) | 2017-01-20 | 2024-01-28 | M et P Pharma AG | Nazális gyógyszerészeti készítmények légszennyezõ anyagoknak való kitettség kockázatainak csökkentésére |
| UA122811C2 (uk) * | 2018-08-10 | 2021-01-06 | Наталія Миколаївна Тихонівська | Фармацевтична композиція |
| EP4210670A1 (en) | 2020-09-08 | 2023-07-19 | Altamira Medica, AG | Compositions for preventing infection |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| HU227563B1 (en) * | 1989-10-31 | 2011-08-29 | Columbia Lab Bermuda Ltd | Process for production of composition for moisturizing of tissue |
| GB9102579D0 (en) * | 1991-01-24 | 1991-03-27 | Glaxo Group Ltd | Compositions |
| GB9103824D0 (en) * | 1991-02-23 | 1991-04-10 | Fisons Ag | Formulation |
| IT1275955B1 (it) * | 1995-03-22 | 1997-10-24 | Dompe Spa | Formulazioni farmaceutiche in forma di gel tissotropico |
| EP0780127A1 (en) * | 1995-12-19 | 1997-06-25 | The Procter & Gamble Company | A nasal spray containing a steroid and a antihistamine |
| AU2462697A (en) * | 1996-04-19 | 1997-11-12 | Hydron Technologies, Inc. | Skin tightening formulation and method of treating skin |
| US6183766B1 (en) * | 1999-02-12 | 2001-02-06 | The Procter & Gamble Company | Skin sanitizing compositions |
| US6967023B1 (en) * | 2000-01-10 | 2005-11-22 | Foamix, Ltd. | Pharmaceutical and cosmetic carrier or composition for topical application |
-
2000
- 2000-12-23 DE DE10064950A patent/DE10064950A1/de not_active Withdrawn
-
2001
- 2001-12-13 WO PCT/EP2001/014655 patent/WO2002051379A2/en not_active Ceased
- 2001-12-13 DE DE60119976T patent/DE60119976T2/de not_active Expired - Lifetime
- 2001-12-13 PT PT01985877T patent/PT1343472E/pt unknown
- 2001-12-13 EP EP01985877A patent/EP1343472B1/en not_active Expired - Lifetime
- 2001-12-13 AT AT01985877T patent/ATE326947T1/de active
- 2001-12-13 DK DK01985877T patent/DK1343472T3/da active
- 2001-12-13 ES ES01985877T patent/ES2266288T3/es not_active Expired - Lifetime
Also Published As
| Publication number | Publication date |
|---|---|
| PT1343472E (pt) | 2006-10-31 |
| EP1343472B1 (en) | 2006-05-24 |
| DE60119976T2 (de) | 2007-01-25 |
| WO2002051379A3 (en) | 2003-03-13 |
| EP1343472A2 (en) | 2003-09-17 |
| ATE326947T1 (de) | 2006-06-15 |
| DE60119976D1 (en) | 2006-06-29 |
| WO2002051379A2 (en) | 2002-07-04 |
| DE10064950A1 (de) | 2002-07-11 |
| ES2266288T3 (es) | 2007-03-01 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL139230A0 (en) | Preparations for the application of anti-inflammatory, especially antiseptic agents and/or agents promoting the healing of wounds to the upper respiratory tract and/or the ear | |
| WO2003099771A3 (en) | Diaryl urea derivatives useful for the treatment of protein kinase dependent diseases | |
| MXPA03010402A (es) | Derivados de 4-amino-5-fenil-7-ciclobutil-pirrolo (2,3-d) pirimidina. | |
| DE60138549D1 (de) | Topische gel-abgabesysteme zur behandlung von hauterkrankungen | |
| BG106095A (bg) | Нови лекарствени състави на базата на антихолинергично активни съединения и бета-миметици | |
| BR0009043A (pt) | Composto, composição farmacêutica, e, método de tratar uma doença em um animal em que a atividade da cisteìna protease contribui para a patologia e/ou sintomatologia da doença | |
| EE200400020A (et) | Asendatud oksasolidinoonid kombineeritud raviks | |
| DK1289517T3 (da) | Farmaceutiske sammensætninger indeholdende cannabidiolderivater | |
| DOP2000000114A (es) | Oxazolidinonas substituidas y su uso | |
| ATE405564T1 (de) | 1h-imidazoä4,5-cüchinolinderivate zur behandlung von protein kinase-abhängigen krankheiten | |
| IL157656A (en) | Metalloproteinase inhibitors, pharmaceutical compositions comprising them and use thereof in the preparation of medicaments for the treatment of diseases mediated by metalloproteinase enzymes | |
| PT1343472E (pt) | Pulverizacao nasal tixotropica | |
| CY1108932T1 (el) | Ενωσεις 4-(ετεροκυκλυλ)-βενζολοσουλφοξιμινης για την θεραπευτικη αγωγη φλεγμονωδων ασθενειων | |
| SE9704644D0 (sv) | New use | |
| ATE240717T1 (de) | Wässrige formulierung zur nasalen verabreichung | |
| DE60043886D1 (de) | Formulierungen mit povidon-iod zur behandlung von wunden | |
| BR0116653A (pt) | Medicamento contendo uma poliamina como substância ativa | |
| PL368686A1 (en) | Novel aminobenzoephenones | |
| CY1106155T1 (el) | Χρηση παραγωγων 3-βενζολοφαινυλοξικων οξεων για την αντιμετωπιση διαταραχων του αμφιβληστροειδους | |
| ATE331523T1 (de) | Statin-therapie zur verbesserung der aufrechterhaltung der kognitiven funktion | |
| DE60007179D1 (de) | Pantothensäure-enthaltende arzneimittel zur behandlung von entzündlichen gelenkserkrankungen | |
| HUP0204180A2 (hu) | Külsőleges készítmény és alkalmazása allergiás dermatitisz kezelésére | |
| BR0317292A (pt) | Derivados de amida de ácido antranìlico e seu uso farmacêutico | |
| ATE302000T1 (de) | Pharmazeutische zusammensetzung enthaltend famotidine für die behandlung von depressionen | |
| ATE293445T1 (de) | Herstellung reiner stereoisomere von tricyclo- (5.2.1.0(2.6) )-dec-9-yl-xanthogenat sowie deren verwendung als arzneimittel |